Clinical Benefit
A Safe, High Potency Probiotic to Promote Good Gut Health.
You deserve relief. But not all probiotics are equal. The trusted, effective formula only found in Visbiome® products contains live natural bacteria created to help in the dietary management of dysbiosis.
Your satisfaction is our priority. Take comfort in our Money Back Guarantee.
Description
High Potency Probiotic Medical Food for the Dietary Management of Dysbiosis
Visbiome is a high potency probiotic medical food intended for the dietary management of dysbiosis associated with Irritable Bowel Syndrome (IBS) and Antibiotic-Associated Diarrhea (AAD).
Visbiome contains milk. Visbiome may contain trace amounts of lactose (less than 0.1g per 100g) and dehydrated skim milk or milk protein (casein and beta-lacto globulin of less than 2mg/kg).
The Science Behind Your Gut
The Critical Nature of Research
Our formulation has had numerous clinical studies proving its efficacy in the management of dysbiosis associated with the following conditions:
Irritable Bowel Syndrome (IBS)
- Reductions in bloating, flatulence & abdominal pain
- Reductions in gut permeability
Ulcerative Colitis (UC)
- Improvements in UC Activity Index Scores
- Reductions in frequency
Antibiotic-Associated Diarrhea (AAD)
- Reduction in antibiotic side effect
Ileal Pouch Management
- Decreased bowel frequency
Collapsible content
View studies reference
View studies reference
- Kim et al. Neurogastroenterol Motil (2005) 17,1-10
- Kim et al. Alimentary Pharmacology Therapeutics 2003; 17:895-904
- Wong et al. Digestive Diseases and Sciences. 2014
- Bazzocchi et al. Digestive and Liver Diseases 2002; 34(2):S48-53.
- Guandalini et al. Journal of Pediatric Gastroenterology and Nutrition. 2010;51:24-30
- Staudacher et al. Gastroenterology 2017;153:936-947
- Ng S.C., et al. Journal of Gastroenterology and Hepatology 2013; 28(10):1624-31
- Boonma et al. Frontiers in Pain Research. 2021
- Kim SE, et al. Journal of Neurogastroenterol Motility. 2015 Jan 1, 21 111-20.
- Michail S, Kenche H. Probiotics Antimicro. Prot. 2011 3:1-7.
- Bibiloni et al. American Journal of Gastroenterology. 2005;100:1539-1546
- Tursi A, et al. Med Sci Monit. 2004;10:126-131. from Visbiome.com
- Huynh Hien Q, et al. Inflamm Bowel Dis 15: 760-768 (2009)
- Sood et al. Clinical Gastroenterology and Hepatology 2009;7:1202-1209
- Tursi A. et al. Am J Gastroenterol. 105:2218-27 (2010)
- Lee J., Moon G., et al. Korean J Gastroenterol Vol. 60 n. 2 94-101 (2012)
- Ng SC, et al. Inflamm Bowel Dis. 2010;16:1286–1298.
- Miele E, et al. American Journal of Gastroenterology. 2009;104:437–443.
- C.P. Selinger et al. Journal of Hospital Infection 2013 Jun;84(2):159-65.
- Gionchetti P, et al. Gastroenterology. 2000;119(2):305-309.
- Gionchetti P, et al. Gastroenterology. 2003b;124(5):1202-1209.
- Mimura T, et al. Gut. 2004;53(1):108 114.
- Pronio, et al. Inflamm Bowel Dis 2008;14:662–668
Lactic Acid Bacteria
Lactic Acid Bacteria
- Lactobacillus acidophilus DSM24735/SD5212
- Lactobacillus plantarum DSM24730/SD5209
- Lactobacillus paracasei DSM24733/SD5218
- Lactobacillus delbrueckii subsp. bulgaricus* DSM24734/SD5210
- Streptococcus thermophilus DSM24731/SD5207
- Bifidobacterium longum± DSM24736/SD5219
- Bifidobacterium breve DSM24732/SD5206
- Bifidobacterium infantis± DSM24737/SD5220
±Reclassified as B. lactis,
*Reclassified as L. helveticus
Inactive Ingredients
Inactive Ingredients
Microcrystalline cellulose, Vegetable capsule (hydroxypropyl methylcellulose)
Storage
INGREDIENTS
Inside the Capsule
Eight carefully selected lactic acid bacteria strains form the De Simone Formulation.
Lactic Acid Bacteria
Inactive Ingredients
Microcrystalline cellulose and vegetable capsule (hydroxypropyl methylcellulose).
Allergen information: Contains milk and may contain trace amounts of lactose. Review the current package label before use.
Dosing Guidelines
How to Take Capsules
Adjustment of the intestinal flora can take a few days or weeks; it may take up to one month for the colonization of the gut to become optimally stable if consumed on a regular basis.
| Daily Intake | CFU | |
|---|---|---|
| Irritable Bowel Syndrome (IBS) | 1 - 4 Capsule(s) | 112.5 - 450 Billion |
| Under Antibiotic Treatment | 4 Capsules | 450 Billion |
| After Antibiotic Treatment (for at least 10 days) | 2 Capsules | 225 Billion |